Clinical Trials Browser

Legius syndrome, Neurofibroma, Neurofibromatosis 1

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses

Attention Deficit Disorder with Hyperactivity, Neurofibromatosis 1

Neurofibromatosis 1, Neurofibrosarcoma

Neurofibromatosis 1

Neurofibromatosis 1

von Hippel-Lindau Disease, Neurofibromatosis 1, Sturge-Weber Syndrome, Tuberous Sclerosis, Neurocutaneous Syndromes

Schwannomatosis, Behavior, Neurofibromatosis 1, Neurofibromatosis 2, Neurofibromatoses

Neurofibromatosis 1

Neurofibromatosis 1

Neurofibromatosis 1

Neurofibromatosis 1, Skin Neoplasms, Neurofibroma, Plexiform

Dyslexia, Learning Disabilities, Neurofibromatosis 1

Neurofibromatosis 1

Neurofibroma, Neurofibromatosis 1, Peripheral Nervous System Neoplasms, Neurofibromatoses, Neurofibroma, Plexiform

Neurofibromatosis 1, Chronic Pain

Hypertension, Neurofibromatosis 1, Neurofibromatoses

Neurofibromatosis 1

Neurofibromatosis 1

Astrocytoma, Neurofibromatosis 1, Optic Nerve Glioma

Glioma, Neurofibromatosis 1

Neurofibromatosis 1

Neurofibromatosis 1, Neurofibrosarcoma

Neurofibromatosis 1, Peripheral Nervous System Neoplasms

Behavior, Brain Neoplasms, Neurofibromatosis 1

Neurofibromatosis 1, Neurofibroma, Plexiform

Neurofibromatosis 1, Neurofibromatoses

Neurofibromatosis 1, Neurofibroma, Plexiform, Optic Nerve Glioma

Neurofibromatosis 1

Neurofibroma, Neurofibromatosis 1

Neurofibromatosis 1, Optic Nerve Glioma

Neurofibromatosis 1, Neurofibromatoses

Neurofibroma, Neurofibromatosis 1

Neurofibromatosis 1

Neurofibromatosis 1

Neurofibromatosis 1

Neurofibromatosis 1, Neurofibroma, Plexiform

Neurofibromatosis 1, Central Nervous System Neoplasms, Optic Nerve Glioma

Neurofibromatosis 1

Neurofibromatosis 1

Autism Spectrum Disorder, Inhibition, Psychological, Neurofibromatosis 1

Neurofibromatosis 1

Neurofibromatosis 1, Neurofibromatosis 2

Neurofibromatosis 1, Muscle Weakness

Brain Neoplasms, Ependymoma, Meningioma, Neurofibromatosis 1, Neuroma, Acoustic, Neurofibromatosis 2

Neoplasms, Neuroblastoma, Neurofibromatosis 1, Sarcoma, Ewing, Osteosarcoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Neurofibromatosis 1

Neurofibromatosis 1, Neurofibroma, Plexiform

Neurofibromatosis 1, Scoliosis

Neurofibromatosis 1

Clinical Trials

Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)

Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1

DoDNAC

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

NF1NAC

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Precision Medicine for Neurocutaneous Syndromes in Western China

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1

Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

NEF-1

Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.

Neurobiology and Treatment of Reading Disability in NF-1

Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1

NF108-BINI

Innovation in the Treatment of Persistent Pain in Adults With NF1: Implementation of the iCanCope Mobile Application- Clinical Trial

Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1

Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

MicroRNAs in Patients With Neurofibromatosis Type 1

NF1

Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery

Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN)

Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments

Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

DPCP to Treat Cutaneous Neurofibromas Associated With NF1

INSPECT

Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial

DCLNF1

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

OPTIMAL-SSI

Medical Treatment of "High-Risk" Neurofibromas

Selumetinib Paediatric NF1 Japan Study

Frameshift Peptides of Children With NF1

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain

Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

COGTRAIN

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1

ASD/NF1inhib

Effects of Physical Training on Bone and Muscle Quality, Muscle Strength, and Motor Coordination in Children With NF1

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)

Whole-body Vibration in Children With Neurofibromatosis Type 1

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Eligibility Screening for a NCI Pediatric Oncology Branch Research Study

Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I

Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Genetic Evaluation of NF1 and Scoliosis Patients

tDCS is NF1